Publication of the 2009 Annual Report

BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the supportive care and treatment of cancer patients, today announced that its 2009 Annual Report, in its capacity as Reference Document, was registered with the French Market Authorities on Tuesday, June 29, 2010. It is available free of charge to the public upon request as per current legal regulations at BioAlliance Pharma’s headquarters – 49 Boulevard du Général Martial Valin, 75015 Paris – and may be consulted at the website (under Investors/Publications).
The Reference Document comprises the annual financial report already published on April 6, 2010, the report by the Chairman of the Supervisory Board on the Board’s activities and on internal controls, the reports from the statutory auditors and their annual fees, and the annual information document.

100630EN_Reference Document